2026-01-28 - LD Düsseldorf - Labrador Diagnostics v. bioMerieux - UPC_CFI_315/2024

Aktenzeichen:
UPC_CFI_315/2024
Datum:
Spruchkörper:
Court of First Instance - Düsseldorf (DE) Local Division
Art:
Decision
Parteien:
Labrador Diagnostics LLC v. bioMérieux SA. a. o.

Kernaussage: 1.

2026-01-28 - LD Düsseldorf - Labrador Diagnostics v. bioMerieux - UPC_CFI_315/2024
🏛️Court of First Instance - Düsseldorf (DE) Local Division• Decision
📅2026-01-28
🔢UPC_CFI_315/2024
Parteien & Vertreter
Kläger / Berufungsführer
Labrador Diagnostics LLC
Christof HÖHNE
Beklagter / Berufungsbeklagter
bioMérieux SA
bioMérieux Deutschland GmbH
bioMérieux Italia S.p.A.
bioMérieux Austria GmbH
bioMérieux Portugal, Lda.
bioMérieux Benelux BV
Benjamin HUSBAND
📋N/A
⚖️Infringement Action
🌐English

1. The Local Division is bound to the new wording of the claims due to the amendment of the patent in suit by a decision of the Central Division in a bifurcated case. 2. In a bifurcated case in which the Court does not find on infringement, the question of validity is no longer decisive for the infringement action

notable
The Düsseldorf LD dismissed an infringement action against bioMérieux's VIDAS 3 diagnostic instrument after the CD Milan had amended the patent claims in parallel revocation proceedings. The court held it was bound to the amended claim wording, which made the sample unit a constructive element of the 'device.' On claim construction, the court held that a 'device' requires sub-components to be spatially linked — not monolithic, but more than a conceptual/functional connection. The VIDAS 3's reagent strip (AU) and sample vial (PAU) were spatially separated with no structural connection forming a device. The court also held that where no infringement is found in a bifurcated case, validity questions become moot.
Stichwörter
Bifurcation; Central Division; amended claims

Entscheidung teilen

Weitere Navigation
Entscheidungen
Rechtstexte
Analysen

Zu Sammlung hinzufügen

0 Einträge hinzufügen zu:

Anmeldung

Registrieren